Rui Shuangyin agreed to acquire 35.56% stake in Anhui Daqian Bio-Engineering Limited Company from Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. for CNY 12.2 million.
May 17, 2022
Share
Rui Shuangyin agreed to acquire 35.56% stake in Anhui Daqian Bio-Engineering Limited Company from Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. (SZSE:300018) for CNY 12.2 million on May 16, 2022. As of April 30, 2022, Anhui Daqian Bio-Engineering Limited Company reported the total assets of CNY 44,387,626.18 and net assets CNY 31,028,631.48. Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd.'s board of directors approved the transaction.
WUHAN ZHONGYUAN HUADIAN SCIENCE & TECHNOLOGY CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sales of electrical power system intelligent record analysis products, time synchronization products, transformer substation integrated automation systems and automated distribution equipment, as well as the provision of related services for its products. The Company operates through two main segments. The Transmission and Distribution and Control Equipment Manufacturing segment is mainly engaged in the research, development, manufacture and sales of power failure recording devices, time synchronization devices, substation integrated automation system and distribution automation equipment. The Medical Health segment is engaged in the research, development and manufacture of medical information products and in-vitro diagnostic equipment.
Rui Shuangyin agreed to acquire 35.56% stake in Anhui Daqian Bio-Engineering Limited Company from Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. for CNY 12.2 million.